Page last updated: 2024-08-24

3-n-butylphthalide and MS (Multiple Sclerosis)

3-n-butylphthalide has been researched along with MS (Multiple Sclerosis) in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bi, Y; Chen, L; Guo, L; Li, B; Shi, W; Wang, Y; Xia, Z1
Dong, L; Huang, Q; Liao, Y; Sun, L; Tang, Y; Wu, Y1

Other Studies

2 other study(ies) available for 3-n-butylphthalide and MS (Multiple Sclerosis)

ArticleYear
Butylphthalide ameliorates experimental autoimmune encephalomyelitis by suppressing PGAM5-induced necroptosis and inflammation in microglia.
    Biochemical and biophysical research communications, 2018, 02-26, Volume: 497, Issue:1

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Apoptosis Regulatory Proteins; Benzofurans; Dose-Response Relationship, Drug; Encephalomyelitis, Autoimmune, Experimental; Male; Mice; Mice, Inbred C57BL; Microglia; Multiple Sclerosis; Necrosis; Neuroprotective Agents; Phosphoprotein Phosphatases; Treatment Outcome

2018
Multiple functional therapeutic effects of DL-3-n-butylphthalide in the cuprizone model of demyelination.
    Life sciences, 2019, Sep-01, Volume: 232

    Topics: Animals; Astrocytes; Axons; Benzofurans; Corpus Callosum; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Gene Expression Regulation; Male; Mice; Mice, Inbred C57BL; Microglia; Multiple Sclerosis; Myelin Sheath; Neuroprotective Agents; NF-kappa B; Oligodendroglia; Signal Transduction

2019